The Importance of Pre-Use Integrity Testing in Sterilizing Filtration - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The Importance of Pre-Use Integrity Testing in Sterilizing Filtration
Pre-use integrity testing of sterilizing-grade filters eliminates the potential adverse effects of filter loading on the integrity-test results, allowing unambiguous correlation with the integrity-test specification established during filter-validation studies.


Pharmaceutical Technology


Russell E. Madsen* is president of the Williamsburg Group, LLC, 18907 Lindenhouse Rd., Gaithersburg, MD 20879, tel. 301.938.4266,
Maik W. Jornitz is group vice-president of global product management, bioprocess of Sartorius Biotech Inc. Theodore H. Meltzer is a consultant for Capitola Consulting Company. Madsen and Meltzer are also members of Pharmaceutical Technology's Editorial Advisory Board.

*To whom all correspondence should be addressed.

Keywords: filtration, integrity testing. sterilization

References

1. F. Hofmann,"Integrity Testing of Microfiltration Membranes." J. Parent. Sci. Tech. 38 (4), 148–159 (1984).

2. J.H. Robertson et al., "PDA Technical Report No. 26: Sterilizing Filtration of Liquids," PDA J. Pharm. Sci. Technol. 52 (S1), (1998).

3. D.B. Pall, "Quality Control of Absolute Bacteria Removal Filters," Bull. Paren. Drug Assoc. 29 (4), 192–204 (1975).

4. A.M. Trotter et al., "Integrity Test Measurements—The Effects of Bacterial Cell Loading," Pharm. Technol. 24 (3), 72–80 (2000).

5. D.C. Grant. and J. G. Zahka, "Sieving Capture of Particles by Microporous Membrane Filters from Clean Liquids," Swiss Contamination Control Quarterly 3 (4a), 160–164 (1990).

6. K.L. Roberts and D.J. Velazquez, "Characterizing the Rating and Performance of Membrane Filters for Liqid Applications Using Latex Spheres," Swiss Contamination Control Quarterly 3 (4a), 71–74 (1990).

7. A.J. Thomas et al., "Detection of L-forms of Pseudomonas aeruginosa during Microbiological Validation of Filters." Pharm. Technol. 14(3), 34–44 (1992).

8. A.M. Trotter et al., "Investigation of a Filter Structure by Microbial Retention Studies: A Synthesis and Elaboration of Prior Findings," PDA J. Pharm. Sci. Technol. 55 (2), 127–133 (2001).


ADVERTISEMENT

RELATED CONTENT
The Role of Glasses in Aseptic Production: A Detail Often Ignored
Risk-Management Assessment of Visible-Residue Limits in Cleaning Validation
The Effect of Carrier Material on the Measured Resistance of Spores
The Importance of Pre-Use Integrity Testing in Sterilizing Filtration
Radiation Sterilization of Parenterals
blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
13%
To select process for new products only
26%
To select processes for both new and legacy products
21%
Do not use QbD
21%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here